Education
About Us
Working with TipRanks
Follow Us
AARON KANTOFF Insider Profile
4 Followers
AARON KANTOFF, Director at Centessa Pharmaceuticals, holds 93.28K shares in Tourmaline Bio (Ticker: TRML), holds 3.17K shares in Avalo Therapeutics (Ticker: AVTX), holds 60.00K shares in Centessa Pharmaceuticals (Ticker: CNTA).
AARON KANTOFF Centessa Pharmaceuticals (CNTA)Director
Centessa Pharmaceuticals (CNTA)
Director
Ranked #43,384 out of 103,781 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+16.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that AARON KANTOFF holds in companies
Most Profitable Insider Trade
The most profitable trade made by AARON KANTOFF
AARON KANTOFF's Trading History
Centessa Pharmaceuticals
Nov 18, 2021
Director
Informative Buy
119.80K
$1.34M
Tourmaline Bio
Sep 09, 2025
Director
Uninformative Buy
99.53K
$4.47M
Avalo Therapeutics
Apr 01, 2025
Director
Uninformative Buy
26.79K
$45.03K
List of latest transactions for each holding click on a transaction to see AARON KANTOFF's performance on stock
You May Also Like
AARON KANTOFF insider profile FAQ
What is the percentage of profitable transactions made by AARON KANTOFF?
The percentage of profitable transactions made by AARON KANTOFF is 50%.
What is the average return per transaction made by AARON KANTOFF?
The average return per transaction made by AARON KANTOFF is 16.40%.
What stocks does AARON KANTOFF hold?
AARON KANTOFF holds: CNTA, TRML, AVTX stocks.
What was AARON KANTOFF’s latest transaction?
AARON KANTOFF latest transaction was an Uninformative Buy of $99.53K.
What was AARON KANTOFF's most profitable transaction?
AARON KANTOFF’s most profitable transaction was an Informative Buy of TRML stock on October 26, 2023. The return on the trade was 103.20%.
What is AARON KANTOFF's role in Centessa Pharmaceuticals?
AARON KANTOFF's role in Centessa Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.